Based on mouse IBD models, molecular analyses of IECs, and ileal biopsy specimens from human CD patients as well as extensive transcriptomic and epigenetic datasets, our study suggests that PLC-β3 promotes intestinal homeostasis and repair after injury through the activation of the Wnt/β-catenin signaling pathway. The gene discussed is PLCB3; the disease is inflammatory bowel disease.